Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 31 32 33 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
CI3 Cluster–InterComponentWare: personalised immunotherapy, 201307 collab existent InterComponentWare AG is cluster partner 2013-07-21
CI3 Cluster–IR2Dx: personalised immunotherapy, 201307 collab existent IR2Dx GmbH is cluster partner 2013-07-21
CI3 Cluster–LBBW: personalised immunotherapy, 201307 collab existent LBBW Venture Capital GmbH is cluster partner 2013-07-21
CI3 Cluster–Life Science Inkubator: personalised immunotherapy, 201307 collab existent Life Science Inkubator GmbH is cluster partner 2013-07-21
CI3 Cluster–M-SPEC (DE): personalised immunotherapy, 201307 collab existent M-SPEC GmbH is cluster partner 2013-07-21
CI3 Cluster–Max Planck: personalised immunotherapy, 201307 collab existent MPI for Polymer Research is cluster partner 2013-07-21
CI3 Cluster–Mediatum: personalised immunotherapy, 201307 collab existent Mediatum is cluster partner 2013-07-21
CI3 Cluster–Merck (DE): personalised immunotherapy, 201307 collab existent Merck Serono GmbH is cluster partner 2013-07-21
CI3 Cluster–MFD Diagnostics: personalised immunotherapy, 201307 collab existent MFD Diagnostics GmbH is cluster partner 2013-07-21
CI3 Cluster–MIG Fonds: personalised immunotherapy, 201307 collab existent MIG Fonds is cluster partner 2013-07-21
CI3 Cluster–Miltenyi Biotec: personalised immunotherapy, 201307 collab existent Miltenyi Biotec GmbH is cluster partner 2013-07-21
CI3 Cluster–NuGen: personalised immunotherapy, 201307 collab existent NuGen Technologies is cluster partner 2013-07-21
CI3 Cluster–Orgentec: personalised immunotherapy, 201307 collab existent Orgentec Diagnostika GmbH is cluster partner 2013-07-21
CI3 Cluster–PerkinElmer: personalised immunotherapy, 201307 collab existent Caliper Life Sciences GmbH is cluster partner 2013-07-21
CI3 Cluster–PharmGenomics: personalised immunotherapy, 201307 collab existent PharmGenomics GmbH is cluster partner 2013-07-21
CI3 Cluster–PlasmAcute (DE): personalised immunotherapy, 201307 collab existent PlasmAcute GmbH is cluster partner 2013-07-21
CI3 Cluster–Prefound: personalised immunotherapy, 201307 collab existent Prefound GmbH is cluster partner 2013-07-21
CI3 Cluster–PricewaterhouseCoopers: personalised immunotherapy, 201307 collab existent PWC is cluster partner 2013-07-21
CI3 Cluster–Protagen: personalised immunotherapy, 201307 collab existent Protagen AG is cluster partner 2013-07-21
CI3 Cluster–ProteoSys: personalised immunotherapy, 201307 collab existent ProteoSys AG is cluster partner 2013-07-21
CI3 Cluster–Qiagen: personalised immunotherapy, 201307 collab existent Ingenuity is cluster partner 2013-07-21
CI3 Cluster–R-Biopharm: personalised immunotherapy, 201307 collab existent Humatrix AG is cluster partner 2013-07-21
CI3 Cluster–Sanofi: personalised immunotherapy, 201307 collab existent Sanofi Aventis Deutschland GmbH is cluster partner 2013-07-21
CI3 Cluster–Strüngmann Group: personalised immunotherapy, 201307 collab existent Athos Service is cluster partner 2013-07-21
CI3 Cluster–Strüngmann Group: personalised immunotherapy, 201307 collab existent Ganymed Pharmaceuticals AG is cluster partner 2013-07-21
CI3 Cluster–Univ Frankfurt: personalised immunotherapy, 201307 collab existent University of Frankfurt (Ffm) is cluster partner 2013-07-21
CI3 Cluster–Univ Mainz: personalised immunotherapy, 201307 collab existent University of Mainz is cluster partner 2013-07-21
CI3 Cluster–Zedira: personalised immunotherapy, 201307 collab existent Zedira GmbH is cluster partner 2013-07-21
InfectControl 2020 project–Germany (govt): grant, 201307– BMBF Zwanzig20 grant €45m for 5 years 2013-07-18
Sigma-Aldrich–Scripps Research Institute: research reagents, 201307– funding of research + commmercialisation of resulting research reagents by Sigma 2013-07-18
Gardner Denver–Kohlberg Kravis Roberts: investment, 201307 acquisition 100% for $3.9b incl assumption of debt 2013-07-16
Merck (DE)–Life Technologies: companion diagnostics, 201307– collab non-excl €na covering serveral platforms + indications Merck Serono 2013-07-16
Pcovery–Galapagos: drug discovery services, 201307– supply services by Argenta to discovery anti-fungal agents 2013-07-16
Sartorius–BlueSens: gas analyser, 201307– collab co-marketing as private label products under SSB brand BioPAT Xgas 2013-07-16
Affimed–SEVERAL: investment, 201307 financing round Series A $14m of subsidiary Amphivena incl MPM Capital + Aeris Capital + Affimed 2013-07-15
Auven Therapeutics–BZL Biologics: anti-PSMA antibody, 201307– excl license + collab €na to develop PSMA-specific ADC by ADC Therapeutics 2013-07-15
Bio Farma (ID)–Artes Biotechnology: vaccine technology, 201307– collab technology transfer of Metavax technology to PT Bio Farma 2013-07-15
Gyros–Merck (DE): immunoassay kits, 201307– collab developm + manufacturing + commercialisation of kits for Gyrolab platform by EMD Millipore 2013-07-15
JnJ–Affimed: TandAb antibodies, 201307– collab developm for hematology with Amphivena + right for Janssen Biotech to acquire Amphivena after IND 2013-07-15
Marinomed–PR&D: public relations, 201101 service existent 2013-07-15
AstraZeneca–Blackfield: cancer genomics, 201307– service application of genomics technology + computational biology for cancer drug developm 2013-07-09
CLC bio–SciEngines: bioinformatics, 201307 collab integration of CLC sequence analysis s/w with SciEngines Rivyera computers 2013-07-09
Dow–Evotec: chemical services, 201307– collab research €na chemical proteomics services to support compound developm at Dow AgroSciences 2013-07-09
Helsinn–Advancell: dermatic, 201307– license ww excl to ATH008 to treat chemotherapy-induced skin damage 2013-07-09
Thermo Fisher–Mitsui: Lipid Search software, 201307– distribution excl ww by Thermo Fisher 2013-07-09
Apeptico–Austria (govt): grant, 201307 grant €500k from FFG via recently established KLPHA promotion scheme 2013-07-08
BioVendor–Scienion: print/spotting technology, 201307 supply use of sciFlexarrayer + other Scienion products for developm + production of immunoassays 2013-07-08
Kreatech–Danaher: investment, 201307 acquisition by Leica Biosystems 2013-07-08
OncoEthix–College Group: public relations, 201307 service existent by College Hill Life Sciences 2013-07-08
OncoEthix–SEVERAL: investment, 201307 financing round Series B CHF18m ($19m) from SVLS + EdRIP + Index Ventures + Endeavour Vision 2013-07-08
Omeicos–Berlin (govt): investment, 201307 seed financing round totalling €500k from HTGF + Pro Fit program of IBB 2013-07-05
Omeicos–High-Tech Gründerfonds: investment, 201307 seed financing round totalling €500k from HTGF + Pro Fit program of IBB 2013-07-05
Omeicos–SEVERAL: investment, 201307 seed financing round €500k from HTGF + Pro Fit program of IBB 2013-07-05
Tecan–Cellendes: lab automation equipment, 201307 collab developm automated 3-D cell cultivation technology with ZHAW 2013-07-04
Karlsruhe Institute of Technology–Helmholtz: IP services, 201307– service collab life sciences technology transfer Ascenion GmbH 2013-07-03
Constitution Medical–Roche: investment, 201307 acquisition $220m upfront + milestones to operate as hematology center of excellence within Roche Dx 2013-07-02
BSM Diagnostica–Eckert & Ziegler: investment, 201307 acquisition 100% 2013-07-01
Debiopharm–Quartz Bio: bioinformatics, 201307–201406 supply service framework agreem to support translational projects at Debiopharm 2013-07-01
Filgen–Biognosys: mass spectrometry, 201307– distribution for 2y right to market + sell Biognosys products in Japan 2013-07-01
GAPVAC project–EU (govt): grant, 201307– FP7 grant €6m 2013-07-01
GSK–Immunocore: ImmTAC technology, 201307– collab research + license agreement with GSK 2013-07-01
Hybrigenics–Dualsystems Biotech: yeast two-hybrid services, 201307 acquisition €na of Y2H activities of Dualsystems by Hybrigenics Services 2013-07-01
Protagen–Zukunftsfonds Heilbronn: investment, 201307 acquisition of Protagen Protein Services GmbH by Zukunftsfonds Heilbronn 2013-07-01
Barilla–Mérieux: mass spectrometry, 201306 collab developm MRM MS technique to determine contaminants in bakery products Mérieux NutriSciences 2013-06-28
Fresenius–Neopharm (IL): investment, 201306 acquisition €na of Fresenius Biotech GmbH by Neopharm Group 2013-06-28
Mérieux–Thermo Fisher: mass spectrometer, 201306 supply existent LC-HRMS Exactive Orbitrap used to develop MRM MS technique by Mérieux NutriSciences 2013-06-28
BioVersys–SEVERAL: investment, 201306 financing round Series A from existing + new investors 2013-06-27
RJ Lee Group–Ionicon: mass spectrometer, 201306– distribution excl in US of Ionicon trace gas analysis products incl service + support 2013-06-27
Roche–Immunocore: ImmTAC technology, 201306– collab research + license $10–20m upfront + $300m+ milestones + royalties per target progr w Genentech 2013-06-27
Biotest–SEVERAL: investment, 201306 capital increase €76m 1.46m new preference shares €52/share 2013-06-26
Celgene–MorphoSys: antibody cancer drug, 201306–201503 collab strat alliance up to €628m incl €70.8m upfront acqu ww rights to MOR202 TERMINATED 3/15 2013-06-26
Middle Peak Medical–SEVERAL: investment, 201306 financing round Series A $8.5m co-led by Wellington Partners + Seventure Partners + incl HTGF 2013-06-26
MorphoSys–Celgene: investment, 201306 acquisition of €46.2m new MorphoSys shares as part of strategic alliance w regard to MOR202 2013-06-26
Analytik Jena–Endress+Hauser: investment, 201306 acquisition additional 10.69% from Jens Adomat raising shareholding of E+H in AJ to over 20% 2013-06-25
Bayer–Seattle Genetics: ADC technology, 201306– collab ww rights for Bayer to use ADC techn w antibodies for several oncology targets 2013-06-25
WBM Health Science–Medicyte: cell technology, 201306– collab promotion of Medicyte products + services in India by WBM 2013-06-25
Artes Biotechnology–Midas Pharma: business development services, 201306– collab Midas supports to find potential partners + markets for Artes 2013-06-24
Dualsystems Biotech–ETH Zürich: drug discovery technology, 201306– license to TriCEPS-based LRC technology 2013-06-24
Evocatal–SEVERAL: investment, 201306 financing round Series B €3.5m from Lanxess + NRW.BANK et al 2013-06-24
Vasopharm–SEVERAL: investment, 201306 financing round Series F €5m led by HeidelbergCapital + Entrepreneurs Fund 2013-06-24
ImaBiotech–Bruker Corp: mass spectrometer, 201206 supply existent most recent instrument addition is 7 Tesla SolariX from Bruker Daltonics 2013-06-20
ImaBiotech–Genfit: drug discovery, 201206– collab long-term incl sharing of tech platforms + mutual drug discovery services 2013-06-20
Boehringer–Karolinska Institutet: therapeutic antibody, 201306– option to acquire fully human MAb program for athersclerosis fr Athera Biotechnologies 2013-06-19
Henkel–c-LEcta: detergent enzymes, 201306– collab development 2013-06-19
Unilabs–Natera: Panorama prenatal test, 201306– distribution of Panorama test in Scandinavia by Unilabs 2013-06-13
Unilabs–Natera: Panorama prenatal test, 201306– distribution of Panorama test in Switzerland by Unilabs 2013-06-13
Valneva–SEVERAL: investment, 201306–201307 financing round €40m capital increase 15m new shares incl FSI + Groupe Grimaud 2013-06-13
Xradia–Carl Zeiss: investment, 201306–201307 acquisition of Xradia Inc renamed Carl Zeiss X-ray Microscopy Inc 2013-06-13
Bruker Corp–ImaBiotech: mass spectrometry software, 201306– distribution of Quantinetix s/w for quantitative MALDI imaging by Bruker 2013-06-10
Harvard Univ–Thermo Fisher: mass spectrometer, 201306 supply Orbitrap Fusion system used by Steven Gygi at Harvard Medical School 2013-06-10
JnJ–Genedata: bioinformatics, 201306 supply existent use of Genedata Expressionist for Mass Spectrometry by Janssen R&D 2013-06-10
PerkinElmer–CTC Analytics: sample preparation technology, 201306– collab supply AxION Sample Manager sample prep + analysis solution by CTC 2013-06-10
Cell Signaling Technology–Trinean: spectrophotometer, 201306– BIOKÉ to distribute Trinean products in Germany 2013-06-07
Cell Signaling Technology–Trinean: spectrophotometer, 201306– BIOKÉ to distribute Trinean products in the Netherlands 2013-06-07
Deloitte Touche Tohmatsu–Thomson Reuters: investment, 201306 acquisition of substantially all assets of Deloitte Recap LLC by Thomson Reuters 2013-06-07
Diagnoplex–Debiopharm: investment, 201306 financing round totalling CHF1.3m incl lead investor Debiopharm 2013-06-07
Diagnoplex–SEVERAL: investment, 201306 financing round CHF1.3m led by Debiopharm 2013-06-07
EBD Group–Informa: investment, 201306 acquisition £30m in cash of EBD Group by Informa 2013-06-07
EBS Technologies–High-Tech Gründerfonds: investment, 201306 financing round Series B €3m incl co-investor HTGF 2013-06-07
EBS Technologies–SEVERAL: investment, 201306 financing round Series B €3m lead investor Earlybird plus HTGF + Brandenburg Capital 2013-06-07
next pagenext page 1 2 3 ... 31 32 33 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top